Reactions Weekly

, Volume 1730, Issue 1, pp 3–3 | Cite as

Post-approval studies in US are "vital to enhancing patient safety"

News item


  1. Gottlieb S. Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA's efforts to hold industry accountable for fulfilling critical post-marketing studies of the benefits, safety of new drugs. Internet Document : 16 Nov 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations